Exagen inc. reports strong q2 2025 results

Carlsbad, calif., july 29, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended june 30, 2025, and recent corporate updates.

XGN Ratings Summary

XGN Quant Ranking